Loading...

343 posters, 5 videos, 2 audios, 18 topics, 33 sessions, 263 authors, 202 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

24th Annual Pain Medicine Meeting 2025

November 13-15, 2025| JW Marriott Austin, Austin, Texas

24th Annual Pain Medicine Meeting 2025 banner

2193733

When Chronic Pain Clouds Acute Diagnosis: A Case of Hip Osteonecrosis in a Medically Complex Patient

Poster Presenter

Bi Mo

Authors

Bi Mo

Affiliations

UCLA

Part of Topic

Medically Challenging Cases

WHEN CHRONIC PAIN CLOUDS ACUTE DIAGNOSIS: A CASE OF HIP OSTEONECROSIS IN A MEDICALLY COMPLEX PATIENT

Jihoo Lee1., Elias Lai1, Jerry Markar2, MD., Sandra Sacks2, MD., MEd, Bi Mo2, MD., MPH.

1. David Geffen School of Medicine, UCLA

2. Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, UCLA

Background: Avascular necrosis (AVN) is a progressive disorder of ischemic osteocyte death leading to structural collapse, most commonly affecting the hip [1]. Risk factors include corticosteroids, alcohol, and systemic disease [2]. MRI enables early diagnosis before joint failure [3], when joint-preserving measures remain effective [4]. Chronic pain may mask evolving pathology; clinicians should suspect AVN when new or worsening symptoms arise following recent therapies, particularly in high-risk patients, to avoid delayed recognition and irreversible joint damage.

Materials and Methods: 

1. Relevant patient consent was obtained for the publication of this case report.

2. As the single case report is devoid of patient identifiable information, it is exempt from IRB review requirements as per University of California, Los Angeles IRB Review Exemption policy.

 Case Report: 

A 78-year-old man with chronic pain and prostate cancer presented with new-onset, debilitating left hip pain impairing ADLs. His longstanding pain was multifactorial, radiculopathy, SI joint dysfunction, piriformis syndrome, and hip tendinopathy/arthropathy, and had been managed with physical therapy, non-opioid adjuvants, and serial injections. Eight months prior, he developed pancytopenia and was started on systemic corticosteroids for presumed autoimmune cytopenia, followed by rituximab and ongoing tapering. A bone marrow biopsy revealed evolving myelodysplastic syndrome. Soon thereafter, his hip pain acutely worsened. MRI demonstrated a confluent marrow lesion in the proximal femur with surrounding edema (Figure. 1), and CT-guided biopsy confirmed steroid-associated osteonecrosis complicated by Pseudomonas aeruginosa infection. He completed 6 weeks of IV antibiotics and remains on oral suppression due to neutropenia. 

Electrodiagnostic studies revealed chronic bilateral L5–S1 radiculopathy. Serial lumbar MRIs showed progressive L4–5 canal narrowing. Early hip MRI had shown only tendinopathy. Despite extensive steroid exposure ( >12 g prednisone equivalents), AVN was initially masked by chronic symptoms and attributed to baseline pathology. This case underscores the need to re-evaluate worsening musculoskeletal pain in high-risk patients, even in the context of presumed chronic disease, to avoid delayed recognition of dual pathology involving osteonecrosis and opportunistic infection.

Discussion: 

Patients with chronic musculoskeletal pain are prone to diagnostic overshadowing, where new symptoms are misattributed to baseline pathology [5]. In this case, evolving hip pain from steroid-induced AVN was initially attributed to longstanding radiculopathy and sacroiliitis, delaying appropriate targeted evaluation. Glucocorticoids remain the leading non-traumatic AVN trigger [6], and immunosuppression may predispose to pathogens like Pseudomonas aeruginosa [7, 8]. Early imaging, biopsy, and multidisciplinary care are essential in high-risk patients with atypical pain progression.

 

1. A.Z. Ansari, D.U. Patel, S. Desai, A. Manawa, S. Patibandla, K. Kratz, Orthopedic Challenges in Avascular Necrosis Management: A Case Report of Surgical Complications and Multidisciplinary Care, Cureus 16 (n.d.) e57629. https://doi.org/10.7759/cureus.57629
2.[4]        K.N. Shah, J. Racine, L.C. Jones, R.K. Aaron, Pathophysiology and risk factors for osteonecrosis, Curr Rev Musculoskelet Med 8 (2015) 201–209. https://doi.org/10.1007/s12178-015-9277-8.
3.  Expert Panel on Musculoskeletal Imaging, A.S. Ha, E.Y. Chang, R.J. Bartolotta, M.D. Bucknor, K.C. Chen, H.B. Ellis, J. Flug, J.R. Leschied, A.B. Ross, A. Sharma, J.M. Thomas, F.D. Beaman, ACR Appropriateness Criteria® Osteonecrosis: 2022 Update, J Am Coll Radiol
4.[10]      A. Lohiya, N. Dhaniwala, U. Dudhekar, S. Goyal, S.K. Patel, A Comprehensive Review of Treatment Strategies for Early Avascular Necrosis, Cureus 15 (n.d.) e50510. https://doi.org/10.7759/cureus.50510. 19 (2022) S409–S416. https://doi.org/10.1016/j.jacr.2022.09.009. M.A. Mont, R. Pivec, S. Banerjee, K. Issa, R.K. Elmallah, L.C. Jones, High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review, J Arthroplasty 30 (2015) 1506-1512.e5. https://doi.org/10.1016/j.arth.2015.03.036.
5.R. Murani, R.H.K. Manocha, Avoiding anchoring bias in unexplained chronic pain: an unexpected diagnosis of synovial osteochondromatosis, BMJ Case Rep 14 (2021) e240462. https://doi.org/10.1136/bcr-2020-24046
6.[12]      M.A. Mont, R. Pivec, S. Banerjee, K. Issa, R.K. Elmallah, L.C. Jones, High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review, J Arthroplasty 30 (2015) 1506-1512.e5. https://doi.org/10.1016/j.arth.2015.03.036.
7.M.-J. Javelot, J. Sergheraert, S. Agbo-Godeau, F. Levy-Weil, S. Laurence, P. Goudot, R.-H. Khonsari, C. Mauprivez, Rituximab as a trigger factor of medication-related osteonecrosis of the jaw. A case report, J Stomatol Oral Maxillofac Surg 121 (2020) 300–304. https://doi.org/10.1016/j.jormas.2019.06.009.
8.[14]      N. Akhras, A. Blackwood, Pseudomonas pelvic osteomyelitis in a healthy child, Infect Dis Rep 4 (2011) e1. https://doi.org/10.4081/idr.2012.e1.
24th Annual Pain Medicine Meeting 2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.